Search

You searched for "screening"

2236 results found

Samsung focuses on the sight impaired and internet security flaws

1 June 2014 | | EYE - General
Smartphone assistive technology for the sight impaired In previous issues we’ve covered some specific smartphones that have been developed for the sight impaired. Samsung are now doing something similar, but in the form of accessories. In March 2014 they announced,...

Glasses for the blind and a safer internet

1 April 2014 | | EYE - General
Google Glass I recently attended a demo of the Google Glass technology (at the TEDx Salford conference). For those who have not come across Glass, it a wearable computer developed by Google. In essence it is a very small computer...

OrCam MyEye – innovative sight assistance (Part 1)

3 June 2021 | | EYE - General
For Jun/Jul 20201 and Aug/Sep 2021 we have a two-part review (see Part 2 here) of an innovative piece of sight impairment technology. The device is called a MyEye, made by OrCam. I was given the opportunity to use the...

Lines, dots, spots and rings in ophthalmology: understanding eponyms

1 April 2015 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Eponymous names are familiar to all who have undergone undergraduate and postgraduate training in medicine. The ability to name a few allows one to stand out among your peers and rare, or not so rare, eponymous syndromes are a favourite...

Refractionist’s shoulder?

1 June 2015 | | EYE - General
After hearing the letter-box, I walked to the front door and stooped down to collect my latest edition of Eye News. I winced. Still, at least it would give me something to pass the time on this, my first day...

Professor Tariq Aslam leaves role as co‑editor of Eye News

1 June 2022 |
Professor Tariq Aslam, co-editor of Eye News for nearly a decade, will be stepping down from his role. Prof Aslam has been a guiding influence on the magazine since he first worked on a publication, the December / January issue...

‘A space that rekindles the fire in my mind’

2 June 2025 | | EYE - Cataract, EYE - Cornea
The end of 2024 offered us many reasons to celebrate, one of which was the eventful, annual UKISCRS conference in London, during which we saw our editor, David Lockington, step into the role of President and lead the society into...

Developments in retinal pigmentation measurement and the hopes of an equitable future

4 August 2025 | | EYE - Vitreo-Retinal, EYE - Imaging
Our AI & Oculomics co-editor, Nima Ghadiri, sat down with Abraham Olvera-Barrios from Moorfields and Anand Rajesh from the University of Washington to discuss their recent international study into retinal pigmentation and its wider clinical, technological and academic applications. Can...

Katie Piper and a host of stars mark World Sight Day 2025 with International Eye Care Charity Orbis

20 October 2025 | Orbis, charity, accessibility, WSD25, World Sight Day
To celebrate World Sight Day, Orbis, the international eyecare charity, hosted an intimate breakfast event this morning at the historic St Pancras London Hotel, situated in King’s Cross. The gathering brought together high-profile people from the worlds of entertainment, fashion,...

Optegra celebrates 15th anniversary and announces expansion plans

18 September 2023 | Optegra, MP, Angela Richardson, Eye Hospital, Anniversary, 15th
Specialist eye hospital Optegra marks its 15th anniversary this month, having opened its first UK hospital in Guildford in 2008.

Robotic assisted orbital surgery (RAOS) – a novel approach to orbital malignancy surgery

3 June 2024 | | EYE - Orbit, EYE - Oculoplastic, EYE - General
Robotic technology in ENT surgery has been used in certain areas of head and neck cancer care but, in this article, we hear of an exciting development from the team at Guy’s & St Thomas’. Advances in surgical robotic technology...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...